You are here: Industry Insights > Market News > Financial Report: Roche

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

98% Bifida Ferment Lysate

rhSOD (cosmetic grade)

Recombinant humanized collagen

Recombinant Humanized Small-molecule Collagen

Recombinant Humanized Small-molecule Collagen Solution

rhSOD

Financial Report: Roche

contractpharmaApril 28, 2017

Tag: Financial Report , Roche

Favorites

1Q Revenues: 12.9 million CHF (+4%)

Comments:Pharmaceuticals Division sales were 10.2 million CHF, up 3%, driven mainly by Tecentriq and Perjeta, partially offset by lower sales of Tamiflu due to generic competition. In the U.S., sales were up 6%, led by recently launched medicines Tecentriq and Alecensa, as well as Xolair and MabThera/Rituxan. In Europe sales were up +1%, with Perjeta, Actemra/RoActemra and Herceptin as the main contributors to growth. Diagnostics Division sales grew 6%, primarily due to immunodiagnostic solutions.

Previous:H&T Presspart, Hovione Technology Enter DPI Pact

Next:FDA Expands Approved Use of Stivarga (regorafenib) to Treat Hepatocellular Carcinoma

Prenetics' IM8 Announces Collaboration with Mayo Clinic to Develop New Line of Premium Supplements

PRNewswireDecember 19, 2024

A New Premium Supplements Brand, Launched Officially on November 18th on IM8health.com

PeproMene Bio, Inc. and the Institute for Follicular Lymphoma Innovation Announce $11M Investment to Advance PMB-CT01 (BAFF-R CAR T cell therapy) for Relapsed/Refractory Follicular Lymphoma

PRNewswireDecember 19, 2024

Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration

PRNewswireDecember 20, 2024

Financial Report: Roche | Pharmasources.com

Corvia Medical Achieves CE Certification for Atrial Shunt Under New EU MDR Standards

PRNewswireDecember 21, 2024

Corvia Medical, Inc.announced today that it has achieved CE certification for the Corvia® Atrial Shunt System under the latest EU Medical Device Regulations (EU MDR 2017/745).

You may like
More>>

Electrochemical-Mechanical Abrasive Polishing Equipment

Standard Type of Electrochemical Polishing Equipment

Phosphorus-free Electrochemical Polishing Reagent for Stainless Steel

Electrochemical Polishing Equipment of Continuous Processing

Cases of Agrochemical Wastewater

Chromium-free Electrochemical Polishing Reagent for Stainless Steel

Agrochemicals biocatalysts

Electrochemical Coloring Production Line for Aluminium Alloy,Titanium Alloy and Stainless Steel

Electrochemical Deburring Machine

Electrochemical Passivating Equipment

Financial Report: Roche

Related News

Prenetics' IM8 Announces Collaboration with Mayo Clinic to Develop New Line of Premium Supplements

PeproMene Bio, Inc. and the Institute for Follicular Lymphoma Innovation Announce $11M Investment to Advance PMB-CT01 (BAFF-R CAR T cell therapy) for Relapsed/Refractory Follicular Lymphoma

Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration

Corvia Medical Achieves CE Certification for Atrial Shunt Under New EU MDR Standards

You may likeMore>>

You may like
More>>